Latest receivables for SXTPW: $570K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest receivables for SXTPW is $570K as of June 2026. That compares with $300K in the prior-year period — up 92.2% year over year. Investors often review this figure alongside 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, SXTPW's receivables moved from $300K to $570K — a 92.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s operating scale or balance-sheet position.
A receivables figure of $570K for SXTPW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting SXTPW's receivables ($570K), review year-over-year change from $300K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.